Alla studier
RekryteringFAS1, FAS2INTERVENTIONELL

A Study to Learn About the Treatment LTP001 in Healthy Participants (Part A) and in Participants With PAH (Part B)

This study is looking into a new medicine called LTP001. It has two main parts. In the first part (Part A), healthy volunteers will take the medicine. This helps doctors learn if LTP001 is safe, how the body handles it, and if there are any side effects. In the second part (Part B), people who have a serious lung condition called Pulmonary Arterial Hypertension (PAH) will receive the medicine. The aim here is to see if LTP001 can help their condition and if it's safe for them. After that, there will be a phase to keep checking on their safety. The study involves both males and females aged 18 to 100 years.

Överblick

Status
Rekrytering
Fas
FAS1, FAS2
Sponsor
Novartis Läkemedel
Inskrivningsmål
232
Starta
24 Oct 2024
Beräknad slutförande
31 dec 2028

Vad handlar denna studie om?

This study is designed to learn more about a new medication called LTP001. It's being tested in stages to make sure it's safe and to understand how it works in the body. Developing new medicines involves careful steps, and this study is an important part of that process.

The study has two parts. The first part, called Part A, will involve healthy volunteers. Healthy people taking part helps researchers understand how the medicine behaves in the body when there are no other health conditions. They'll be checking things like how much medicine gets into the blood, how long it stays there, and if there are any side effects. This step is really important for safety before the medicine is given to people who are unwell.

The second part, called Part B, will include individuals who have Pulmonary Arterial Hypertension (PAH). PAH is a serious condition that affects the blood vessels in the lungs. In this part of the study, researchers want to see if LTP001 can improve the condition of people with PAH and if it continues to be safe for them. Participants in Part B will already be receiving their usual PAH treatments, and LTP001 will be given in addition to these. The study also includes a safety follow-up period to keep an eye on participants after they've finished taking the study medicine.

Viktiga punkter

  • New medicine LTP001 is being studied for safety and how it works.
  • First part is for healthy volunteers, second part for people with PAH.
  • Compares LTP001 to a placebo (dummy medicine).
  • You'll have regular medical checks and tests if you take part.
  • Participation is voluntary; you can withdraw at any time.

Vem kan vara berättigad?

This study is open to both men and women between the ages of 18 and 100.

For Part A, if you are a healthy adult, you might be able to join. However, you cannot have any major heart problems or other serious health issues that could affect how your body handles the medicine or put you at risk during the study. If you are female, you must not be able to have children (for example, if you've been through menopause or had a hysterectomy).

For Part B, you must have a confirmed diagnosis of PAH and be on stable doses of your usual PAH medicines. You'll need to be able to walk between 150 and 450 metres in 6 minutes. You cannot have any medical conditions that would put you at higher risk in the study. Women who could become pregnant must use very effective birth control. Men must agree to use a condom during sex while taking the study medicine and for a day after stopping it. You also can't have had a bad reaction to similar medicines before.

Kan denna studie passa dig?

Svara på dessa snabba frågor för att se om du kan vara berättigad. Detta är endast en vägledning — forskarteamet fattar det slutgiltiga beslutet.

  1. Är du mellan 18 och 100 år gammal?
  2. If you have PAH, are you on stable doses of your usual PAH medicines?
  3. Do you have any serious heart conditions or other major health problems?
  4. If you are female, can you become pregnant?
  5. If male and sexually active, are you willing to use a condom during the study?
Svara på varje fråga för att se ditt resultat.

Vad innebär deltagande?

If you decide to take part, you will be given either the new medicine, LTP001, or a 'placebo'. A placebo looks like the real medicine but contains no active ingredients; this helps researchers compare the effects of the new medicine fairly. You won't know if you're getting the active medicine or the placebo.

You will have regular visits to the clinic for check-ups. These visits will involve various assessments, such as blood tests, heart checks (ECG), and physical examinations to make sure you're doing well and to see how the medicine is affecting your body. For those with PAH, your walking ability may also be assessed.

The total length of time you'll be involved in the study will vary depending on which part you join, but it will involve taking the study medication for a period, followed by regular check-ups. You will be told the exact duration before you agree to take part.

Potentiella risker och fördelar

Taking part in a study like this could offer potential benefits, such as access to a new treatment that isn't widely available yet, which might help your condition if you have PAH. You'll also receive careful medical monitoring. However, there are also potential risks; you might experience side effects from the study medicine, or for those in Part B, the medicine might not help your PAH. The placebo also means you might not get the active treatment. You have the right to withdraw from the study at any time, for any reason, without it affecting your usual medical care.

Platser (87)

  • Arizona Pulmonary Specialists Ltd
    Verifierat postnummer
    Scottsdale, USA· Rekrytering
  • UC Irvine Medical Center
    Verifierat postnummer
    Orange, USA· Rekrytering
  • Stanford Medical Center
    Verifierat postnummer
    Stanford, USA· Rekrytering
  • Univ Colorado Hospital
    Verifierat postnummer
    Aurora, USA· Rekrytering
  • Central Florida Pulmonary Group
    Verifierat postnummer
    Orlando, USA· Rekrytering
  • University of South Florida
    Verifierat postnummer
    Tampa, USA· Rekrytering
  • Emory University School of Medicine
    Verifierat postnummer
    Atlanta, USA· Rekrytering
  • U of Kansas Medical Center
    Verifierat postnummer
    Kansas City, USA· Rekrytering
  • Norton Infectious Diseases Specialists
    Verifierat postnummer
    Louisville, USA· Rekrytering
  • Tufts medicinska centrum
    Verifierat postnummer
    Boston, USA· Rekrytering
  • Lahey sjukhus och medicinskt centrum
    Verifierat postnummer
    Burlington, USA· Rekrytering
  • Sky Integrative Medical Center SKYCRNG PPDS
    Verifierat postnummer
    Ridgeland, United States· Rekrytering

Vanliga frågor

What is Pulmonary Arterial Hypertension (PAH)?

PAH is a serious condition where the blood vessels in your lungs become narrowed, making it harder for your heart to pump blood through them. This can cause symptoms like shortness of breath and tiredness.

Vad är en 'placebo'?

A placebo is a 'dummy' treatment that looks just like the real medicine but doesn't contain any active drug. Giving some people a placebo helps researchers fairly compare the new medicine's effects against doing nothing extra.

Will I know if I'm getting the actual medicine or a placebo?

No, during the study, neither you nor your study doctor will know if you are receiving the active medicine or the placebo. This helps prevent bias in the results.

Hur länge kommer studien att pågå?

The total length of time you would be involved in the study will be explained in detail by the study team. It will include time taking the medicine and follow-up appointments.

Kan jag lämna studien när som helst?

Yes, you are free to leave the study at any point, for any reason, without it affecting your future medical care.

Hur du får reda på mer

Novartis Läkemedel

Prata alltid med din läkare eller specialist innan du bestämmer dig för att delta i en studie.

Intresserad av att delta?

Registrera ditt intresse

Dela dina uppgifter och forskarteamet för "A Study to Learn About the Treatment LTP001 in Healthy Parti…" kommer att kontakta dig om du kan vara berättigad. Prata alltid med din läkare innan du går med på att delta.

Diskussion

Gemenskapsdiskussion

Drivs av vårt forum på community.patient.info. Var vänlig och respektfull — detta är inte medicinsk rådgivning.